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ABSTRACT 
We have prepared a conjugate of epidermal growth factor (EGF) and ferritin that 
retains substantial binding affinity for cell receptors and is biologically active. 
Glutaraldehyde-activated EGF was covalently linked to  ferritin to  produce a 
conjugate that contained EGF and ferritin in a  1:1  molar ratio. The conjugate 
was separated from free ferritin by affinity chromatography using antibodies to 
EGF. Monolayers of human epithelioid carcinoma cells (A-431) were incubated 
with EGF:ferritin at 4~  and  processed for transmission electron microscopy. 
Under these conditions, ~ 6 ￿  105 molecules of EGF:ferritin bound to the plasma 
membrane of each cell. In the presence of excess native EGF,  the number of 
bound ferritin particles was reduced by 99%, indicating that EGF:ferritin binds 
specifically to cellular EGF receptors. At 37~  cell-bound EGF:ferritin rapidly 
redistributed in the plane of the plasma membrane to form small groups that were 
subsequently internalized into pinocytic vesicles. By 2.5 min at 37~  32% of the 
cell-bound EGF:ferritin was localized in vesicles. After 2.5  min, there was  a 
decrease in the proportion of conjugate in vesicles with a concomitant accumula- 
tion of EGF:ferritin in multivesicular bodies. By 30 min, 84% of the conjugate 
was located in structures morphologically identified as multivesicular bodies or 
lysosomes. These results are consistent with other morphological and biochemical 
studies utilizing I~I-EGF and fluorescein-conjugated EGF. 
KEY  WORDS  hormone receptors  growth 
factor  ￿9  endocytosis  lysosomes 
Epidermal growth factor (EGF)  ~ initiates a com- 
plex  series  of  cellular  events  which  ultimately 
1 Abbreviations used in  this paper:  DMEM/BSA, Dul- 
becco's  Modified Eagle Medium containing 0.1% bovine 
serum  albumin;  EGF,  epidermal growth  factor;  I~I- 
EGF, l~ZI-labeled  epidermal  growth factor; MVB, multi- 
vesicular body; PBS, 9.5  mM sodium phosphate (pH 
7.4) containing 4.14 mM KCI and 0.137 M NaCI. 
results in increased DNA synthesis and cell divi- 
sion (see references 6 and 7 for reviews). Cultured 
cells that are responsive to EGF contain specific, 
saturable  plasma  membrane  receptors  for  this 
hormone (9, 19). As a first step in examining the 
biochemical mechanism by which EGF exerts its 
growth-promoting  effects,  we  have  investigated 
the metabolic fate of EGF using both ~I-labeled 
EGF and fluorescein-conjugated EGF. Our stud- 
ies  (4,  17)  have  indicated that cell-bound EGF 
rapidly is internalized into endocytic vesicles and 
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exposure of cells to EGF results in an apparent 
decrease in the number of cell-surface  receptors, 
it was postulated that the EGF receptor is inter- 
nalized  along with the hormone (4,  1). Das and 
Fox (12) have labeled a putative EGF receptor 
with a  photoreactive derivative of I~I-EGF and 
located degradation products of the receptor in 
the  lysosomal  fraction  of the  cell.  These  data 
provide direct experimental support for the pro- 
posal  that  EGF-induced  down  regulation  of 
plasma  membrane receptors involves internaliza- 
tion of the EGF:receptor complex. The internali- 
zation of hormone:receptor complexes has been 
proposed for a number of polypeptide hormones 
(3, 23, 18). 
Although the proposed  endocytic vesicles con- 
taining  EGF  have  been  visualized using  biologi- 
cally  active  fluorescent  derivatives of EGF  (17, 
27),  these  experiments  do  not  afford  sufficient 
resolution  to  determine  in  detail the cell surface 
events that occur before the internalization of the 
hormone:receptor  complex.  Since  ferritin-conju- 
gated  ligands  have  been  useful  tools  in  other 
ultrastructural  studies  of receptor  ligand interac- 
tions  (2,  13,  22),  we  have  taken  a  similar  ap- 
proach in the study of EGF binding. 
In this communication,  we report the prepara- 
tion of an EGF:ferritin conjugate that is univalent 
with respect to EGF, contains no ferritin dimers, 
is  biologically  active,  and  binds  to  cell  surface 
EGF receptors  in a  specific manner.  This conju- 
gate has allowed us to visualize and quantitatively 
study at the molecular level the topography of the 
EGF:receptor complex on the plasma  membrane 
and to determine the fate of cell-bound EGF as it 
is  internalized  and  transported  to  lysosomes.  A 
preliminary report of these  results  has been  pre- 
sented (11). 
MATERIALS  AND  METHODS 
Mouse EGF was isolated from the submaxillary  gland 
(25).  The immunoglobulin fraction of rabbit antiserum 
against mouse EGF (10) and mI-EGF (4) were prepared 
by published methods. Ferritin (cadmium-free, six times 
recrystallized) and  an  8%  solution of electron micros- 
copy grade glutaraldehyde were purchased from Polysci- 
ences, Inc.  (Warrington, Pa.); rabbit anti-horse ferritin 
was  purchased  from  Miles  Laboratories,  Inc.  (Kan- 
kakee, Ill.). Polylysine was obtained from Sigma Chem- 
ical Co. (St. Louis, Mo.). 
Synthesis of EGF.'Ferritin 
EGF was coupled to ferritin by a modification of the 
general  method  of  Kishida  et  al.  (20).  In  a  typical 
experiment, 9 mg of EGF containing a tracer amount of 
~I-EGF  (final  sp  act  =  6.7  x  10  s  cpm/mg)  was 
dissolved in 2.5 ml of 50 mM sodium phosphate buffer 
(pH 7.3) and activated by the addition of a  1,000-fold 
excess  of glutaraldehyde  (1.8  ml of an  8%  solution). 
After stirring at 35"C for 3 h, the unreacted glutaralde- 
hyde was removed by gel filtration on a 45  x  1.5 cm 
column of Sephadex  G-25  (fine) that  was  equilibrated 
and eluted with 50 mM sodium phosphate (pH 7.3). In 
all  experiments,  the  amount of EGF in a  sample was 
calculated  from  the  amount  of  radioactivity  present, 
based on the assumption that native EGF reacted to the 
same extent  as ~I-EGF. Ferritin concentrations  were 
determined  by  the  absorbance  at  280  nm  using  an 
extinction coefficient (E~  ~ ) of 12.7. Molar concentra- 
tions of EGF and ferritin were calculated based on tool 
wt of 6,045 and 750,000, respectively. 
Activated EGF from the excluded peak of the Sepha- 
dex G-25 column was  immediately coupled to ferritin. 
In the experiment shown in Fig. 1,780 mg of ferritin (in 
7.8 ml of 0.15 M NaC1) was added to 6.3 mg of activated 
EGF in 14 ml of 50 mM sodium phosphate buffer (pH 
7.3). After stirring at room temperature for 5 h and then 
at 4~  for 50 h, the solution was concentrated to 5 ml in 
an Amicon ultrafiltration cell (Amicon Corp., Scientific 
Sys. Div., Lexington, Mass.), using a UM-2 membrane, 
and  unreacted  EGF was  removed by gel filtration on 
Bio-Gel A  1.5  m  (Bio-Rad Laboratories,  Richmond, 
Calif.). Fig. 1  A shows that 7.3 % of the radioactive EGF 
applied  to  the  column  co-migrated  with  monomeric 
ferritin. The peak fraction of unreacted EGF eluted in 
tube 67. Some radioactivity eluted with the salt fraction 
but was found to be only partially dialyzable through a 
Spectrapore  membrane  (Spectrum  Medical Industries, 
Inc., Los Angeles, Calif.) (tool wt cutoff -3,000). The 
salt peak probably contained a mixture of 1~I- and other 
degradation products of I~I-EGF. 
Fractions 39-46  (Fig.  1A),  containing EGF:ferritin 
plus  free  ferritin  were  pooled  and  the  ferritin  was 
pelleted by ultracentrifugation (105,000 g, 2 h). 63.8% 
of the radioactivity pelleted with the ferritin. The pellet, 
which contained EGF and ferritin in a 1 :  17 molar ratio, 
was  dispersed  in  5  ml  of  50  mM  sodium  phosphate 
buffer  (pH 7.3),  and  applied to the Bio-Gel A  1.5  m 
column. As shown in Fig. 1B, 95% of the radioactive 
EGF eluted  as a  single  symmetrical peak  with mono- 
meric ferritin.  Fractions  34-45  were  pooled,  and  the 
ferritin  was  again  pelleted in  the  ultracentrifuge.  The 
pellet contained 94 % of the radioactivity and was further 
purified by affinity chromatography. 
Separation of EGF:Ferritin from Free 
Ferritin by Anti-EGF 
Affinity Chromatography 
An anti-EGF affinity column was prepared  by cou- 
pling  36.3  mg of the  IgG fraction of rabbit  antiserum 
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FmURE  1  Gel filtration of EGF:ferritin. Samples (4-5 
ml) were applied to a  100  ￿  1.4 cm column of Bio-Gel 
A  1.5  m  equilibrated and eluted with  10 mM sodium 
phosphate buffer (pH 7.3). The flow rate was 17 ml/h 
and 2-ml fractions were collected. Standards of ferritin, 
EGF, and  lmI-Na eluted with peak values at fractions 
41, 67, and 77, respectively. (A) Elution profile of the 
concentrated EGF-ferritin reaction mixture (see text for 
details).  (B)  Rechromatography  of concentrated frac- 
tions 39-46 from Fig. 1A  (184/.Lg  of EGF and 403 mg 
of ferritin). ((7) Elution profile of affinity purified EGF: 
ferritin (9.7 p.g of EGF and 1.78 mg of ferritin) (see text 
for details). 
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against EGF to  10 ml of activated AcA22 ultragel by 
the method of Ternyck and Avrameas (30). To separate 
EGF:ferritin conjugate from free ferritin, an aliquot of 
pooled fractions 34-45 from Fig. 1 B was applied to the 
anti-EGF affinity column at room temperature in 5 ml 
of  phosphate-buffered saline  (PBS).  The  free  ferritin 
and any nonimmunoreactive conjugate were eluted with 
100 ml of PBS at room temperature. This unadsorbed 
protein did not compete with 1~I-EGF binding sites in 
the radioreceptor assay. The adsorbed protein then was 
eluted with 50 ml of 0.2 M HCI adjusted to pH 2.2 with 
2  M glycine. Fig. 2  shows that 92% of the ferritin and 
11%  of  the  radioactivity appeared  in  the  PBS  wash. 
Fractions 110-124 (Fig. 2)containing the protein eluted 
by the HCl-glycine buffer were pooled and centrifuged 
(105,000 g,  2  h). The pellet was dispersed in 4  ml of 
PBS and applied to the Bin-Gel A  1.5 m column (Fig. 
1 C).  The  acidic  conditions used  to  elute  the  affinity 
column induced some  aggregation of the conjugate as 
indicated by the appearance of a high molecular weight 
peak (fractions 29-33) of radioactivity and protein. 74 % 
of the radioactivity and 72% of the protein eluted in a 
peak (fractions 37-45) with the same elution volume as 
monomeric ferritin. These fractions were  pooled, con- 
centrated by  pelleting in the ultracentrifuge, and con- 
tained EGF and ferritin in approximately a 1:1.25 molar 
ratio.  This  preparation  of  monomeric  conjugate  was 
CPM 
xiO.  a  Io 
(x-x)  8 
6 
4 
i 
f 
I 
! 
II 
II 
II 
II 
II 
16  ii 
14  III 
1 
12  I  I 
I 
SALT  ~I'~ACI  D --"~ 
I 
I 
I 
20  40  60  80  I00  I'~  140 
MILLILITERS 
I10 
I00 
9O 
80 
70 
OD2eo 
60  (.~) 
5O 
40 
3O 
20 
I0 
FIGURE  2  Affinity  chromatography  of  EGF:ferritin. 
An aliquot (25  t~g of EGF and 54.5 mg of ferritin) of 
the EGF:ferritin from the A  1.5 m column described in 
Fig. 1 B was applied to the anti-EGF affinity column and 
eluted as described in Materials and Methods. 5- and 2- 
ml fractions were collected during the PBS (1-100 ml) 
and HCI/GIy (100-145 ml)elutions, respectively. 
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tin conjugate. 
EGF:Ferritin Binding and Thymidine 
Incorporation Assays 
The  ability of EGF:ferritin to bind to cellular EGF 
receptors was tested using a  1Zq-EGF competitive bind- 
ing  assay.  Confluent  monolayers  of  human  foreskin 
fibroblasts  (grown  as  previously  described  [4])  were 
washed twice with 4 ml of Hanks' solution at 37~  The 
cells were  incubated at  37~  in  1.5  ml  of Dulbecco's 
Modified  Eagle's  Medium  plus  0.1%  bovine  serum 
albumin (DMEM/BSA) containing varying amounts of 
either native EGF, EGF:ferritin, or EGF:ferritin prein- 
cubated with anti-ferritin. At 1 h, the cells were tested 
for their capacity to bind 1mI-EGF  (12 ng/ml, sp act = 
1.19 ￿  10  s cpm/ng) as previously described (4). 
Thymidine incorporation assays were  performed on 
quiescent confluent monolayers of human foreskin fibro- 
blasts by published procedures (5). 
Localization of Cell-Bound E G F:  Ferritin 
by Electron Microscopy 
Human  epithelioid  A-431  cells were  propagated  in 
10%  fetal calf serum  (17). To label cells at 4~  with 
EGF:ferritin  for  electron  microscopy,  monolayer cul- 
tures of A-431 cells in 60-ram tissue culture dishes were 
washed twice at 4~  with Hanks' solution. DMEM/BSA 
(1.5  ml at 4~  containing EGF:ferritin (100 nM) was 
added  and the  cultures were  incubated for 40  rain at 
4~  Cultures were washed five times with a total of 10 
ml  of  cold  Hanks'  solution  containing  0.1%  bovine 
serum albumin followed by two 3-ml washes with cold 
Hanks' solution. The cells were either fixed at this time 
or  further incubated at  37~  in DMEM/BSA  for the 
indicated time intervals, and the cultures were rinsed at 
4~  with  Hanks'  solution  and  fixed.  Fixation  was 
achieved by adding cold  5% glutaraldehyde in 0.1  M 
cacodylate buffer (pH 7.2) containing 1 mM CaClz and 
incubating for 2  h  at room  temperature.  The cultures 
were rinsed with buffer and postfixed with 1.3 % osmium 
tetroxide in the same buffer for 2 h and dehydrated into 
ethanol. Monolayers were released from the polystyrene 
dishes  with  propylene  oxide.  The  pelleted  cells were 
embedded in Epon  812,  and 60-nm sections were ex- 
amined unstained in a Hitachi 11E microscope. 
In  certain  experiments,  monolayers  of  A-431  cells 
were  prefixed with formaldehyde at either 4 ~ or 23~ 
before  binding  EGF:ferritin.  To  prefix  cells  at  4~ 
cultures  were  washed  twice  at  4~  with  PBS,  then 
incubated for 20 min at 4~  with 1% formaldehyde in 
PBS. The cells were  washed with cold PBS, quenched 
with 0.1  M  glycine in PBS, and washed with cold PBS. 
To prefix cells at 23~  the above steps were performed 
at  room  temperature  and  0.15%  formaldehyde  was 
used.  EGF:ferritin  was  incubated with  prefixed  cells, 
and the ceils were processed for electron microscopy as 
described, These light prefixations did not significantly 
reduce the binding of EGF:ferritin nor was the nonspe- 
cific binding increased. 
The binding of EGF:ferritin to monolayers of A-431 
cells  at  37~  was  also  examined.  After washing with 
warm Hanks' solution, DMEM/BSA  (1.5  ml at 37~ 
containing EGF:ferritin  (100  raM)  was  added.  After 
incubating at  37~  for  30  s,  2  rain,  or  10  rain,  the 
cultures were rapidly washed five times with a total of 10 
ml  of  warm  Hanks'  solution containing 0.1%  bovine 
serum albumin followed by a  wash with warm Hanks' 
solution. The cells were fixed at room temperature with 
5% glutaraldehyde and processed for electron micros- 
copy as described above. 
Quantification of Cell-Bound E G F:  Ferritin 
The amount of EGF:ferritin associated with various 
cellular organelles  (plasma membrane, endocytic vesi- 
cles, and lysosomes) was determined by counting ferritin 
particles  in randomly  selected  unstained  sections.  For 
each determination, at least 750 ferritin particles were 
counted, and the percentage of particles bound to the 
plasma membrane and the percentage inside endocytic 
vesicles and lysosomes was calculated. Lysosomes were 
identified morphologically and, for the purpose of this 
tabulation, all multivesicular bodies were scored as lyso- 
somes. 
The degree of grouping of EGF:ferritin bound to the 
cell  surface  was  also  determined.  If  an  EGF:ferritin 
particle was >30 nm away from adjacent EGF:ferritin 
particles,  it was  scored  as  a  singlet.  Ferritin  particles 
within  30  nm  of  adjacent  particles  were  arbitrarily 
defined as a group, and the number of particles in the 
group was recorded. 
RESULTS 
Characterization of the E G  F:  ferritin 
Synthetic Reaction 
The procedure for the synthesis of EGF:ferritin 
was designed to yield a conjugate containing EGF 
and  ferritin  in  a  1:1  molar  ratio.  In  the  first 
synthetic  step,  EGF  was  activated  with  a  large 
molar excess of glutaraldehyde  to  prevent dimer 
formation.  Since  EGF  contains  only  one  free 
amino group  (26),  a  monoactivated EGF  should 
be  formed.  In  a  control  experiment,  glutaralde- 
hyde-activated EGF was chromatographed on the 
Bio-Gel  A  1.5  m  column.  All  the  EGF  eluted 
with the  same  volume  as native EGF,  indicating 
that no detectable polymerization occurred. 
To  evaluate  the  percentage  of  EGF  that  was 
activated  by  excess  glutaraldehyde,  glutaralde- 
hyde-treated EGF  was prepared,  separated  from 
residual  glutaraldehyde,  and  reacted  with  a  17- 
fold molar excess of polylysine (mol wt -13,000) 
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EGF-ferritin reaction. We consistently found that 
~10% of the total EGF was coupled to polylysine 
as judged by gel filtration of the reaction products 
on Sephadex G-75. We interpret this to mean that 
only 10% of the EGF is activated by glutaralde- 
hyde  under  these  conditions.  Such  results  are 
consistent with previous reports of low reactivity 
of the NH2-terminal amino group of EGF (17). 
In  the  second  synthetic  step,  monoactivated 
EGF was reacted with ferritin. Since <10% of the 
EGF was coupled to  ferritin (see  Materials and 
Methods and Fig. 1  A ), the molar ratio of ferritin 
to reactive EGF exceeds 10:1. Therefore, on the 
basis of statistical considerations, we estimate that 
<5% of the conjugate will contain more than one 
EGF  molecule per  ferritin particle.  The  above 
calculations are  consistent with  the  observation 
that,  when  free  ferritin was  removed from  the 
reaction product by affinity chromatography, the 
conjugate contained EGF and ferritin in approxi- 
mately a 1:1 molar ratio. 
To confirm that the conjugate contained only 
monomeric ferritin, a  dilute  solution of affinity 
purified  conjugate  was  applied  to  parlodion- 
coated grid and examined directly with the elec- 
tron microscope. Greater than 95 % of the ferritin 
particles observed were monomeric. 
The  covalent linkage of  EGF  to  ferritin was 
stable for at least 2 mo when stored in PBS at 4~ 
Binding o  f E G F:  Ferritin to 
Cellular Receptors 
The ability of EGF:ferritin to bind to cellular 
receptors was evaluated by measuring the reduc- 
tion of lz~I-EGF binding by a l-h preincubation of 
human fibroblasts with  increasing concentration 
of EGF:ferritin (Fig. 3). The data show that EGF: 
ferritin reduced the binding of 1~I-EGF ~8% as 
efficiently as native EGF. When EGF:ferritin was 
preincubated with anti-ferritin the  conjugate did 
not inhibit I~I-EGF binding, thereby confirming 
that  no free  EGF was present and that the  ob- 
served  inhibition is  due  to  EGF conjugated to 
ferritin. The addition of anti-ferritin alone or anti- 
ferritin plus ferritin did not alter the  binding of 
1~I-EGF. 
Competitive  binding  experiments  in  which 
EGF:ferritin was added simultaneously with ~mI- 
EGF were performed also. In these experiments, 
the conjugate was again ~ 8 % as efficient as native 
EGF in competing for l~I-EGF-binding  sites. 
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Competition of either native EGF or EGF: 
ferritin and mI-EGF for binding to human fibroblasts. 
Cells were incubated with increasing concentrations of 
either EGF, EGF:ferritin, or anti-ferritin-treated EGF: 
ferritin for 1 h at 37~  washed, and reincubated with 
I=I-EGF (see Materials and Methods for details). The 
results are expressed as specific binding relative to the 
binding of  I~I-EGF alone.  The  values represent  the 
average of duplicate cultures which varied by <10%. ￿9 
EGF; [3,  EGF:ferritin;  <>,  EGF:ferritin  preincubated 
with anti-ferritin. EGF:ferritin  (containing 116  ~g of 
ferritin and 725 ng of EGF) was incubated with 1.09 mg 
of  anti-ferritin in  225  /~1  of  PBS  for  2  h  at  room 
temperature, then for 24 h at 4~  The precipitate was 
removed by centrifugation, and an aliquot of the super- 
nate that would correspond to the indicated concentra- 
tion of conjugate if no precipitation had occurred was 
added to the cells. 
Biological Activity of EGF:Ferritin 
The relative ability of EGF and EGF:ferritin to 
stimulate the synthesis of DNA in quiescent hu- 
man fibroblasts was compared. Fig. 4  shows the 
effect  of  increasing concentrations  of  EGF  or 
EGF:ferritin conjugate  on  the  incorporation of 
radioactive thymidine. One-half maximal stimula- 
tion occurred at 0.9  x  10 -1~ M EGF and 1.2  x 
10 -1~ M conjugate; therefore, the EGF:ferritin is 
-75%  as effective as native EGF in this assay. 
EGF:ferritin  that  had  been  preincubated  with 
either anti-ferritin or anti-EGF did not stimulate 
thymidine  incorporation  above  control  levels. 
Anti-ferritin did  not reduce  the  mitogenicity of 
native EGF. 
It is not possible to define the reasons for the 
different efficiencies observed for EGF:ferritin in 
the competitive binding and thymidine incorpora- 
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Fl~tIl~ 4  Stimulation of DNA replication as a func- 
tion of EGF or EGF:ferritin concentration. Confluent 
quiescent fibroblasts were stimulated at t  =  0 with the 
indicated concentration of EGF, EGF:ferritin, or EGF: 
ferritin preincubated with either anti-EGF or anti-ferri- 
tin. The incorporation of [aH]thymidine  (27 mCi/mg, 1 
/~Ci/ml)  was measured during a 4-h interval beginning at 
20  h.  The  data  represent  the  average of  duplicate 
cultures which varied by <10%.  O,  EGF;  x,  EGF- 
ferritin; Q, EGF-ferritin preincubated with anti-ferritin; 
ZX, EGF-ferritin preincubated with anti-EGF. EGF:fer- 
ritin was preincubated with anti-ferritin as described in 
the legend of Fig. 3. The anti-EGF preincubation was 
identical except that  0.83 mg of anti-EGF was substi- 
tuted for the anti-ferritin. 
tion assays because the relationship between the 
binding of EGF to  its receptor  and  subsequent 
metabolic alterations is  complex  and  biochemi- 
cally  undefined.  However,  the  presence  of 
"spare" receptors  (4,  1) and the large difference 
in time of incubation in the two assays probably 
contributed to the discrepancy in the assays. 
Observation of Cell Surface-Bound 
EGF:Ferritin by Electron Microscopy 
Binding of EGF:ferritin to cellular EGF recep- 
tors was visualized directly with the electron mi- 
croscope. In these studies, we used human epithe- 
lioid  carcinoma  cells  (A-431)  because  of  their 
capacity to  bind much larger quantities of EGF 
compared  to  human  fibroblasts  (17,  14).  Bio- 
chemical  studies  have  shown  that  A-431  cells 
internalize and  degrade  I~I-EGF in  a  manner 
similar to fibroblasts (17).  Subconfluent cultures 
of these epithelioid cells grow as monolayers with 
a  cobblestone-like appearance. Numerous mem- 
brane folds were observed on the apical surfaces, 
and the plasma membranes of adjacent cells were 
interdigitated and joined by desmosomes. 
Monolayers of A-431 cells were incubated with 
EGF:ferritin (100 nM) at 4~  for 40 min; electron 
micrographs of unstained sections (Fig. 5) show 
ferritin particles associated with the plasma mem- 
brane. EGF:ferritin was detected on the plasma 
membrane of all cells examined, and the density 
of ferritin particles varied less than  twofold be- 
tween  different  cells.  While  some  binding was 
observed on the bottom of the cell, the density of 
ferritin particles was greater on the apical surface 
and at cell-cell borders. 
Averaged  over  the  entire  cell  surface,  -12 
ferritin particles were bound per  /zm  of plasma 
membrane in 60-nm thick sections. To establish 
that  EGF:ferritin  was  binding to  specific  and 
saturable EGF receptors, an excess (20/zg/ml) of 
native EGF was added together with EGF:ferri- 
tin.  In  sections  of  these  control  cultures,  one 
ferritin core  was  observed per  20  tim of mem- 
brane; therefore,  nonspecific binding was  -  1%. 
The specific binding observed in the above exper- 
imental cultures corresponds to 200 particles per 
/zm  z.  On  the  basis  of  our  estimation  that  the 
surface area of these 30-/xm-Diam cells is 2,800 
/zm  2, we calculate that each cell bound ~6  x  105 
molecules of EGF:ferritin. Under the conditions 
used  to  bind EGF:ferritin (4~  40  min), these 
cells bind -1  ￿  106 molecules of lmI-EGF/cell at 
saturating concentrations of lzSI-EGF. 
Although no large patches or large clusters of 
EGF:ferritin were  detected  on  the  cell  surface, 
binding was not entirely random. As can be seen 
in Fig. 5 and Table I, ceil-bound EGF:ferritin was 
frequently located in small groups. The degree of 
grouping was not reduced if the cells were lightly 
fixed with formaldehyde at either 4 ~ or 23~  (see 
Materials and Methods) before binding the con- 
jugate, thereby suggesting that the pattern seen in 
Fig. 5  was not due to clustering after binding at 
4~ 
Internalization o  f E G F  :  Ferritin 
The fate of cell-bound EGF:ferritin was inves- 
tigated by binding the conjugate to monolayers at 
4~  removing unbound EGF:ferritin, and  then 
warming the cultures to 37~  (see  Materials and 
Methods).  As shown in Table I,  the  amount of 
EGF:ferritin located in groups containing five or 
more  particles increased from 27  to  44%  when 
cells were warmed to 37~  for 30 s. The binding 
pattern at 30 s is illustrated in Fig. 6.  Although 
some of the ferritin clusters were located in coated 
pits,  the  majority were  located  on areas  of the 
membrane with no distinguishing  features. 
HA/GLER ET AL.  Binding  and Internalization of Epidermal Growth Factor  387 FIrURE  5  Binding of EGF:ferritin at 4~  Monolayers of A-431 ceils were incubated with EGF:ferritin 
(100 nM) for 40 min at 4~  washed, and prepared for electron microscopy as described in Materials and 
Methods. Conjugate bound to the plasma membrane is predominantly dispersed, but some small dusters 
are present (arrows).  x  66,000. 
FIGURE 6  Redistribution of cell-bound EGF:ferritin at 37~  Cultures were preloaded with conjugate at 
4~  as  in  Fig.  5  and  warmed  to  37  ~ C  for 0.5  rain  (see  Materials  and  Methods).  EGF:ferritin was 
frequently located in dusters (arrow). x  66,000. 
FIGURE 7  Internalization of EGF:ferritin. Cultures were preloaded with conjugate at 4~  as in Fig. 5 
and warmed to 37~  for 2.5  rain. Clusters of EGF:ferritin are seen apparently in the process of being 
internalized into small endocytic vesicles (a-c). EGF:ferritin is seen inside a membrane fold that appears 
to be fusing with the plasmalemma (d) to form a large vesicle, x  66,000. 
The  distribution  of EGF:ferritin  in  cells  after 
2.5 min at 37~  is shown in Figs. 7 and 8. Ferritin 
particles  can  clearly  be  seen  inside  cytoplasmic 
vesicles with  a  diameter  of  ~120  nm  (Fig.  8). 
These vesicles were most likely formed by adsorp- 
tive  pinocytosis.  Fig.  7  (a-c)  shows  a  series  of 
progressively  deeper  plasmalemmal  indentations 
and illustrates the probable sequence of events by 
which groups of EGF:ferritin are internalized into 
pinocytic vesicles. In this instance, the invaginated 
pits are coated; however, most conjugate-contain- 
ing endocytic vesicles and many plasma membrane 
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Binding of EGF:Ferritin at 4~  and Quantitation of the Redistribution after Warming to 37~ 
Location of cell-bound EOF:ferritin 
Cell surface  Internalized 
Time at 37"C  Singlet  Doublet  Triplet  Quadruplet  5 or more  Vesicle  Lysosome ~ 
min  %  % 
0  29  19  15  10  27 (7.0)  0  0 
0.5  15  11  19  11  44 (5.7)  0  0 
1.0  16  13  15  11  45 (7.2)  <5  0 
2.5  13  15  12  10  18 (6.5)  32 (8.0)  0 
15.0  4  4  4  2  3 (5.6)  22 (7.7)  61 (63.3) 
30.0  1  1  1  1  2 (8.5)  10 (7.6)  84 (54.5) 
Monolayers of A-431 cells were incubated with EGF:ferritin (100 riM) for 40 min at 4~  unbound conjugate was 
removed, and the cells were warmed to 37~  for the indicated times and processed for electron microscope 
observation. The amount and distribution of EGF:ferritin on the cell surface and located inside the cell was 
quantitated (see Materials and Methods) and the results are expressed as percent of total cell-bound conjugate. 
The  numbers in parentheses indicate the  average number of ferritin particles associated with that  particular 
structure. In this experiment, an average of 12 ferritin particles (range = 10.6-14.7) was observed per/xm of cell 
membrane or underlying cytosol in these 60-nm sections. 
* For the purpose of this tabulation, all multivesicular  bodies were scored as lysosomes. 
invaginations did  not have  the  thickened mem- 
brane characteristic of coated  pits.  EGF:ferritin 
was occasionally observed in vesicles with a diam- 
eter of -400 nm. These could have been formed 
by fusion of the  tip of a  plasma membrane fold 
with the  membrane as  shown in Fig. 7d.  How- 
ever, it is possible that these apparent vesicles are 
actually exterior to the cell and appear as vesicles 
due to sectioning artifacts. Because of these uncer- 
tainties, these 400-nm vesicles (a small minority 
of the total number of vesicles) were not included 
in the quantitation in Table I. Experiments are in 
progress to determine their true nature. 
As shown  in Table I,  32%  of the  cell-bound 
EGF:ferritin was in endocytic vesicles within 2.5 
min  at  37~  In  60-nm  sections,  each  vesicle 
profile contained an average of 8.0 EGF:ferritin 
particles;  73%  of  the  hormone  was  located  in 
vesicles that contained between 5 and 13 particles 
per vesicle. It is of interest to note the similarity 
between the number of particles in vesicles at 2.5 
min  (8.0)  and  the  number of  particles  in  cell 
surface groups (7.2) at 1 min. Also, note that the 
decrease  in  the  number of  cell  surface  groups 
between 1 and 2.5 min quantitatively  corresponds 
to the amount of EGF:ferritin incorporated into 
vesicles during the same time period. These quan- 
titative similarities together with the direct obser- 
vation of invaginations (Fig. 7a-c)  strongly sug- 
gest that, during the 37~  incubation, small clus- 
ters of EGF:ferritin-receptor complexes are  seg- 
regated in the plane of the plasma membrane and 
that  these  groups  are  rapidly endoeytosed  into 
120-nm vesicles. 
By  15  min at  37~  84%  of the  EGF:ferritin 
had  been  internalized  (Table  I).  27%  of  the 
internalized EGF:ferritin was in endocytic vesicles 
located  throughout the  cytoplasm. EGF:ferritin- 
containing  vesicles  located  near  multivesicular 
bodies (MVBs) were smaller (65 nm Diam) than 
those  nearer  the  plasma  membrane  (120  nm 
Diam). 73% of the internalized EGF:ferritin was 
in structures morphologically identified as MVBs 
with a diameter of -500 nm (Fig. 9). Profiles of 
these  MVBs  contained an  average  of 63  EGF: 
ferritin  particles.  Most  of  the  EGF:ferritin  in 
MVBs  was  bound to  the  convex surface  of the 
internal vesicles or located in small clusters on the 
limiting membrane of the MVBs (Figs. 9 and 10). 
The vesicles inside the MVBs were approximately 
the same size  (65 nm Diam) as the EGF:ferritin- 
containing cytoplasmic vesicles located  near the 
MVBs, and suggest that the internal vesicles were 
derived from  the cytoplasmic vesicles. Since the 
ferritin  particles  were  bound  to  the  inside  of 
cytoplasmic vesicles and  to  the  outer surface  of 
the MVB vesicles, the mchanism by which cyto- 
plasmic  vesicles  and  MVBs  fuse  probably pro- 
duces an eversion of the sideness of the membrane 
of the vesicle. 
HAIGLER ET AL,  Binding  and Internalization of Epidermal Growth Factor  389 IqGUR~ 8  Endocytic vesicles containing EGF:ferritin. Cultures were preloaded with conjugate at 4~  as 
in Fig. 5 and warmed to 37~  for 2.5 rain. Arrows indicate endocytic vesicles containing EGF:ferritin. 
x 66,000. 
IqGURE 9  Multivesicular  bodies containing EGF:ferritin. Cultures were preloaded with conjugate at 4~ 
as in Fig. 5 and warmed to 37~  for 15 min. The plasmalemma (P) is nearly depleted of EGF:ferritin 
while cytoplasmic vesicles (arrows) and  multivesicular bodies  (M)  contain  most  of  the  cell-bound 
conjugate, x  66,000. 
Internalized EGF:ferritin represented 94%  of 
the cell-bound EGF:ferritin in cells that had been 
warmed to 37~  for 30 rain (Table I). 84% of the 
internalized EGF:ferritin was present in MVBs or 
lysosomes. These  structures were  frequently lo- 
cated adjacent to the cell nucleus (Fig. 10). EGF: 
ferritin was never observed in the  nucleus or in 
the stacked Golgi cisternae. Occasionally, a  few 
ferritin cores were  observed associated with the 
rough endoplasmic reticulum. 
The data presented in Table I are summarized 
in  Fig.  12  and  show  the  temporal  relationship 
between the binding  of EGF:ferritin  to the plasma 
membrane,  clustering  within  the  plane  of  the 
plasma membrane, internalization into endocytic 
vesicles,  and  accumulation of hormone in lyso- 
somes or MVBs. 
Binding and Internalization of 
E G F:  Ferritin at 37~ 
The quantitative data presented in Table I  on 
the  binding and endocytosis of EGF:ferritin are 
based  on  experiments in  which  cells  preloaded 
with  the  conjugate  at  4~  were  subsequently 
warmed to 37~  To eliminate the possibility that 
the incubation at 4~  induced an unphysiological 
result, we  did  a  similar study entirely at  37~ 
Monolayers were  incubated at  37~  with EGF: 
ferritin  (100  nm) for  30  s,  2  min, or  10  rain, 
rapidly rinsed at 37~  and fixed at room temper- 
390  ThE  JOURNAL OF  CELL BIOLOGy'  VOLUME 81, 1979 F/GUVm 10  Accumulation  of EGF:ferritin  in  multivesicular  vesicles.  Cultures  were  preloaded  with 
conjugate  at  4"C as  in  Fig.  5  and  wanned  to  37~  for  30  rain.  EGF:ferritin  was  observed  inside 
multivesicular bodies located primarily on the convex surface of internal vesicles (large arrow) and also in 
cytoplasmic vesicles (small arrows). N, nucleus, x  66,000. 
FIGURE 11  Binding of EGF:ferritin at 37~  Cultures were incubated with EGF:ferritin (100 nM) at 
37~  for 10 min, washed, and prepared for electron microscopy as described in Materials and Methods. A 
multivesicular body containing EGF:ferritin (M1) is seen beside a multivesicular body devoid of conjugate 
(M2). At this time, some of the hormone is bound to the plasmalemma (P). 
ature  (see  Materials  and  Methods).  The  results 
are summarized in Table II. 
The  amount  of EGF:ferritin  bound  increased 
with  time  at  approximately  the  same  rate  as  the 
binding  of  lzZI-EGF.  At  0.5  min,  none  of  the 
EGF:ferritin  was  located  in  groups  containing 
greater  than  three  particles  and  probably  is  a 
reflection  of low  binding  density  after  this  brief 
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Fate of cell-bound EGF:ferritin. The data  FIrURE  12 
presented  in Table I  are summarized to show the per- 
centage of the total cell-bound conjugate that was asso- 
ciated  with  the  plasma  membrane  (O),  cell  surface 
groups  containing  five or  more  ferritin  particles  (x), 
cytoplasmic vesicles (A), or lysosomes  (￿9  as a function 
of the time of incubation at 37~ 
exposure.  At  the  2-min  point,  clusters  of  the 
conjugate that contained an average of nine parti- 
cles were detected on the cell surface. At the same 
point,  14%  of  the  cell-bound  EGF:ferritin  was 
located  in  120-nm-diameter  vesicles  that  con- 
tained  an average of 8.6 particles. These vesicles 
appeared  identical  to  the  120  nm  EGF:ferritin- 
containing vesicles seen  in cells preloaded  at 4~ 
and then warmed to 37~  (see Fig. 8). At 10 min, 
74%  of the  bound  EGF:ferritin  had  been  inter- 
nalized.  One-half of the internalized EGF was in 
120-rim vesicles that  contained an average of 8.6 
particles. The other half of the internalized EGF: 
ferritin was located in MVBs  (Fig.  11) that  con- 
tained  an  average of 17.6  particles.  These  struc- 
tures appear similar to the 500-nm MVBs seen in 
cells  preloaded  with  EGF:ferritin  at  4~  and 
warmed to 37~  for 15 rain (see Fig. 10). 
DISCUSSION 
A  1:1  conjugate  of  EGF:ferritin  has  been  pre- 
pared  that  retains  substantial  binding  activity for 
cellular EGF receptors  and  is biologically active, 
The  number  of EGF:ferritin particles bound  per 
cell  is  in  good  agreement  with  the  number  of 
cellular EGF  receptors  as  determined  biochemi- 
cally  using  a~ZI-EGF.  Each  EGF:ferritin  particle 
observed on the cell membrane corresponds  to a 
single  EGF-binding  site  because:  (a)  there  is no 
multimeric ferritin in the conjugate,  (b)  <5%  of 
the conjugate contains more than one molecule of 
EGF per ferritin particle, and  (c) the nonspecific 
binding  of EGF:ferritin  is  only  1%  of  the  total 
binding. 
TABLE II 
Quantitation of the Binding and Internalization of EGF:Ferritin at 37~ 
Location  of cell-bound  EGF:ferritin 
Cell surface  Internalized 
Incubation  time  Singlet  Doublet  Triplet  Quadruplet  5 or more  Vesicle  Lysosome* 
min  %  % 
0.5  50  27  23  0  0  0  0 
2.0  47  13  8  4  14  (9.0)  14 (8.6)  0 
10.0  2  7  8  5  4  (6.0)  36 (8.6)  38 (17,6) 
Monolayers of A-431 cells were incubated with EGF:ferritin (100 nM) for the indicated times at 37~  washed to 
remove unbound hormone, and processed for electron microscope observation. The amount and distribution of 
EGF:ferritin on the cell surface  and located inside the cell was quantitated (see Materials and Methods), and the 
results are expressed as percentage of total cell-bound conjugate. The numbers in parentheses indicate the average 
number of ferritin particles in that particular structure. In this experiment, 1.2, 3.9, and 8.6 ferritin cores were 
observed per/xm of membrane or underlying cytosol at 0.5, 2, and 10 rain, respectively. Binding was reduced by 
~99% if an excess (20 v,g/ml) of native EGF was added to the binding media. 
* For the purpose of this tabulation, all multivesicular  bodies were scored as lysosomes. 
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the plasma membrane (Fig. 6). Most of the bind- 
ing occurs on the apical surface and on the inter- 
digitated membrane folds at cell-cell borders. The 
observed  binding  capacity  of  these  numerous 
membrane folds at cellular borders is in agreement 
with  and  explains  the  prominent  staining of this 
region by fluorescein-conjugated EGF (17). 
Singer  (28)  has  proposed  that  clustering  is  a 
prerequisite  for  endocytosis  of  receptor-bound 
ligands.  Although it clearly has been established 
that multivalent ligands induce clustering of their 
receptors  (29,  13),  the  fate  of univalent  ligands 
has  not  been  extensively  investigated.  In  this 
report,  we have  used  the univalent  ligand EGF: 
ferritin  to  study  cell  surface  events  that  occur 
before endocytosis, At 4~  or in lightly prefixed 
cells,  distribution of the plasma membrane-bound 
EGF:ferritin  was  not  entirely  random  (Fig.  5). 
Initially,  ~25%  of the EGF receptors appear to 
be  located  in  groups of five or more  (Table  I). 
When  unfixed  cells  were  warmed  to  37~  the 
conjugate rapidly redistributed in the plane of the 
membrane  such  that  nearly 50%  was located in 
small groups (Table I). The redistribution was not 
dependent  on metabolic energy since it occurred 
in glucose-free media containing sodium azide and 
dinitrophenol (unpublished results). The essential 
features  of surface  binding and  redistribution  of 
EGF:ferritin have been confirmed in another di- 
mension by en face examination of whole mounted 
cells  (21).  A  hypothesis  consistent  with  these 
results is that the binding of EGF to its receptor 
alters the configuration of the receptor in such a 
way as to predispose it to either (a) associate with 
other EGF:receptor complexes or  (b) bind  to a 
specific area  of the membrane predetermined  to 
be  the  site  of clustering.  The  initial  nonrandom 
distribution  of EGF receptors may reflect a  lim- 
ited  tendency  of  unoccupied  receptors  to  self 
associate. 
Time-course  studies  revealed  that  the  clusters 
of EGF:ferritin  on  the  cell  surface  rapidly were 
pinocytosed  into  vesicles  (average  Diam  =  120 
rim). The internalization occurred at both coated 
and  noncoated  regions  of  the  membrane.  The 
formation of endocytic vesicles required metabolic 
energy since  no  EGF:ferritin-containing  vesicles 
were  observed  when  cells  were  incubated  with 
conjugate  in  glucose-free  media  containing  so- 
dium  azide  and  dinitrophenol  (unpublished  re- 
sults).  With  use  of horseradish  peroxidase  as  a 
marker,  it  has  been  shown  biochemically  that 
native EGF stimulates  the rate  of endocytosis in 
A-431  cells  by  approximately  fivefold  (unpub- 
lished results).  Therefore,  it is possible  that cell- 
bound EGF stimulates its own internalization into 
endocytic  vesicles.  The  recent  observation  that 
EGF directly enhances the ability of A-431 mem- 
branes  to phosphorylate  endogenous proteins  in 
vitro (8) raises the possibility that the phosphoryl- 
ation  of specific membrane  proteins  may be  in- 
volved in clustering and/or pinocytosis. 
EGF:ferritin-containing  vesicles  apparently 
serve  to  shuttle  the  hormone  to  multivesicular 
bodies.  Although  histochemical  studies  will  be 
required to conclusively identify the multivesicular 
bodies as secondary lysosomes, the rapidity with 
which  l~I-tyrosine  is  released  into  the  media 
subsequent to the binding of ~z~I-EGF (4) suggests 
that  lysosomal  degradation  begins  at  approxi- 
mately  the  same  time  that  EGF:ferritin  is  ob- 
served to accumulate in multivesicular bodies (Fig. 
12). 
EGF:ferritin was not observed to associate with 
any other cellular  organelles  to a  significant ex- 
tent, although a small amount was seen in rough 
endoplasmic reticulum. The significance, if any, of 
this association is unknown. 
Since coupling of EGF to ferritin results in large 
changes  in  the  physiochemical properties  of the 
hormone, results obtained with EGF:ferritin must 
be analyzed with caution. Nonetheless, the follow- 
ing  independent  observations  suggest  that  the 
metabolic  fate  of  EGF:ferritin  is  an  accurate 
marker of the physiological process by which EGF 
is  internalized.  First,  EGF:ferritin  is  univalent 
with  respect  to EGF;  therefore,  artifacts due  to 
valence of the ligand were avoided.  Second, the 
conjugate retained nearly complete biological ac- 
tivity (Fig. 4). Third,  the kinetics of the binding 
and  internalization  of EGF:ferritin  observed  by 
electron microscopy are similar to those inferred 
from biochemical studies of the interaction of ~I- 
EGF  with  fibroblasts  and  A-431  cells  (4,  17). 
Fourth,  the  kinetics  of binding  and  the  cellular 
location  of  internalized  fluorescein-conjugated 
EGF observed by fluorescence microscopy in A- 
431  cells  (17)  is  consistent  with  the  results  re- 
ported herein. Fifth, Gordon et al. (16) have used 
quantitative electron microscope autoradiography 
to  investigate  the  fate  of  ~I-EGF  in  human 
fibroblasts. They found that the hormone initially 
localized to the plasma membrane.  With incuba- 
tion at 37~  they observed a  decrease  in mem- 
brane-bound  hormone  with  a  concomitant  in- 
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lysosomes. The  observed accumulation of EGF: 
ferritin in lysosomes in A-431 cells (Tables I and 
II) is in agreement with the temporal sequence of 
internalization  reported  by  these  investigators. 
Since  the  cellular fate  of EGF:ferritin was very 
similar to the fate of both ~I-EGF and fluores- 
cein-conjugated  EGF,  it  is  probable  that  these 
derivatives of EGF accurately reflect the physio- 
logical interaction of EGF with its target cell. 
Recent evidence suggests that coated pits (24, 
15) on the plasma membrane are involved in the 
process of adsorptive endocytosis. Using a ferritin 
conjugate of low density lipoprotein, Anderson et 
al.  (2) showed that this complex is rapidly inter- 
nalized in cultured fibroblasts. They obtained con- 
vincing evidence that low density lipoprotein ini- 
tially was  bound  to  coated  pits  on  the  plasma 
membrane  and  that  subsequently the  coated pit 
regions  were  endocytosed  into  coated  vesicles. 
The electron microscope autoradiography experi- 
ments of Gordon et al. (16) suggest that ~I-EGF 
also  binds  with  some  preference  for  coated  pit 
regions of human fibroblasts. Although EGF:fer- 
ritin did bind to coated pits (Fig. 7) in A-431 cells, 
much of the cell-bound EGF:ferritin seemed to be 
internalized  by  a  process  that  did  not  involve 
coated pits or coated vesicles. Additional experi- 
ments will be required to determine quantitatively 
the role of coated pits in this process. 
Schlessinger et  al.  (27)  have  investigated the 
fate  of  cell-bound  rodamine-labeled  EGF  in 
monolayers of living 3T3 fibroblasts, using a sen- 
sitive video intensification microscope system. In 
contrast to  the  results obtained with fluorescent 
EGF  (17) in A-431  cells, they found that roda- 
mine-conjugated EGF formed patches before in- 
ternalization. The data of Schlessinger et al. (27) 
and  the  ~I-EGF  autoradiography  experiments 
showing EGF binding preferentially to coated pits 
(16)  raise the  possibility that  details of the  cell 
surface  distribution  of  EGF  receptors  may  be 
different in fibroblasts and A-431 cells. Investiga- 
tion of the topography of the EGF:ferritin binding 
to  fibroblasts  should  determine  whether  these 
observed differences are the consequence of cell 
morphology (fibroblastic or epithelioid), the state 
of  transformation,  and/or  the  number  of EGF- 
receptors per cell, or are due to the limitations in 
the methods of visualization. 
It is now  clear that,  subsequent  to  the  initial 
binding  of  EGF  to  the  plasma  membrane,  the 
hormone,  probably together with its receptor, is 
internalized  rapidly  in  endocytotic vesicles  and 
eventually degraded in lysosomes (4,  12, 17, 27, 
and Fig. 12). However, we can only speculate (7) 
concerning the stage or stages of this process at 
which the signals for the many observed metabolic 
alterations are generated. 
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